Category: 57825-30-6

Liu, Yong-Hai; Li, Da-Li; Li, Qin-Hua; Yang, Jun-Fang; Lu, Lu-De published an article about the compound: 1-(Bromomethyl)-4-ethylbenzene( cas:57825-30-6,SMILESS:CCC1=CC=C(CBr)C=C1 ).Formula: C9H11Br. Aromatic heterocyclic compounds can be classified according to the number of heteroatoms or the size of the ring. The authors also want to convey more information about this compound (cas:57825-30-6) through the article.

A novel and convenient approach for the preparation of [3R-(3α,4β,5α,6β)]-2-[7-chloro-1-(4-ethylbenzyl)-5-methyl-1H-indol-3-yl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol starting from 7-chloro-5-methylindole by three steps was developed. The product was achieved in 72% yield.

There is still a lot of research devoted to this compound(SMILES：CCC1=CC=C(CBr)C=C1)Formula: C9H11Br, and with the development of science, more effects of this compound(57825-30-6) can be discovered.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Chai, Xiaoyun; Zhang, Jun; Yu, Shichong; Hu, Honggang; Zou, Yan; Zhao, Qingjie; Dan, Zhigang; Zhang, Dazhi; Wu, Qiuye published the article 《Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols》. Keywords: triazolyl difluorophenyl aralkylamino propanol preparation antifungal activity computational chem.They researched the compound: 1-(Bromomethyl)-4-ethylbenzene( cas:57825-30-6 ).Computed Properties of C9H11Br. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:57825-30-6) here.

Based on the results of computational docking to the active site of the cytochrome P 450 14α-demethylase (CYP51), a series of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols, e.g., I, as analogs of fluconazole were designed, synthesized, and evaluated as antifungal agents. Results of preliminary antifungal tests against eight human pathogenic fungi in vitro showed that all the title compounds exhibited excellent activities with broad spectrum.

There is still a lot of research devoted to this compound(SMILES：CCC1=CC=C(CBr)C=C1)Computed Properties of C9H11Br, and with the development of science, more effects of this compound(57825-30-6) can be discovered.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Zhang, Qiao; Wang, Simin; Zhang, Qian; Xiong, Tao published the article 《Radical Addition-Triggered Remote Migratory Isomerization of Unactivated Alkenes to Difluoromethylene-Containing Alkenes Enabled by Bimetallic Catalysis》. Keywords: difluoromethyl alkene preparation diastereoselective; alkene radical addition isomerization.They researched the compound: 1-(Bromomethyl)-4-ethylbenzene( cas:57825-30-6 ).Quality Control of 1-(Bromomethyl)-4-ethylbenzene. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:57825-30-6) here.

A fascinating alkene remote migratory isomerization engendered by carbon radical addition to C=C bond in alkenes Ar(CH2)nCH=CH2 (Ar = C6H5, 4-FC6H4, 2-pyridyl, etc.; n = 2, 4, 5, 6, 7) via bimetallic catalysis has been disclosed. A diverse array of alkenes bearing distantly incorporated the difluoromethylene ArCH=CH(CH2)mCF2C(O)R (m = 1, 4, 5, 6, 9; R = OMe, OEt, morpholin-4-yl, etc.) functionality have been expediently obtained. The retainment of C=C bonds in products could serve as an useful synthetic platform furnishing otherwise difficult to access value-added densely functionalized difluoromethylene containing mols. In addition, some exptl. studies have been implemented to shed light on the probable mechanism.

There is still a lot of research devoted to this compound(SMILES：CCC1=CC=C(CBr)C=C1)Quality Control of 1-(Bromomethyl)-4-ethylbenzene, and with the development of science, more effects of this compound(57825-30-6) can be discovered.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Oh, Sangmi; Kim, Sungbum; Kong, Sunju; Yang, Gyongseon; Lee, Nakyung; Han, Dawoon; Goo, Junghyun; Siqueira-Neto, Jair L.; Freitas-Junior, Lucio H.; Song, Rita published the article 《Synthesis and biological evaluation of 2,3-dihydroimidazo[1,2-a]benzimidazole derivatives against Leishmania donovani and Trypanosoma cruzi》. Keywords: dihydroimidazobenzimidazole derivative preparation antileishmanial antitrypanosomal; 2,3-Dihydroimidazo[1,2-a]benzimidazole; Anti-parasitic activity; Chagas disease; Leishmaniasis.They researched the compound: 1-(Bromomethyl)-4-ethylbenzene( cas:57825-30-6 ).Electric Literature of C9H11Br. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:57825-30-6) here.

A high-throughput (HTS) and high-content screening (HCS) campaign of a com. library identified 2,3-dihydroimidazo[1,2-a]benzimidazole analogs as a novel class of anti-parasitic agents. A series of synthetic derivatives were evaluated for their in vitro anti-leishmanial and anti-trypanosomal activities against Leishmania donovani and Trypanosoma cruzi, which were known as the causative parasites for visceral leishmaniasis and Chagas disease, resp. In the case of Leishmania, the compounds were tested in both intracellular amastigote and extracellular promastigote assays. Compounds I and II showed promising anti-leishmanial activity against intracellular L. donovani (3.05 and 5.29 μM, resp.) and anti-trypanosomal activity against T. cruzi (1.10 and 2.10 μM, resp.) without serious cytotoxicity toward THP-1 and U2OS cell lines.

There is still a lot of research devoted to this compound(SMILES：CCC1=CC=C(CBr)C=C1)Electric Literature of C9H11Br, and with the development of science, more effects of this compound(57825-30-6) can be discovered.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Zhou, Bingcheng; Li, Xun; Li, Yan; Xu, Yaochun; Zhang, Zhengxi; Zhou, Mi; Zhang, Xinglong; Liu, Zhen; Zhou, Jiahai; Cao, Chunyang; Yu, Biao; Wang, Renxiao researched the compound: 1-(Bromomethyl)-4-ethylbenzene( cas:57825-30-6 ).Recommanded Product: 1-(Bromomethyl)-4-ethylbenzene.They published the article 《Discovery and Development of Thiazolo[3,2-a]pyrimidinone Derivatives as General Inhibitors of Bcl-2 Family Proteins》 about this compound( cas:57825-30-6 ) in ChemMedChem. Keywords: thiazolo pyrimidinone preparation Bcl2 protein inhibitor SAR. We’ll tell you more about this compound (cas:57825-30-6).

A class of compounds with a common thiazolo[3,2-a]pyrimidinone motif has been developed as general inhibitors of Bcl-2 family proteins. The lead compound was originally identified in a random screening of a small compound library using a fluorescence polarization-based competitive binding assay. Its binding to the Bcl-xL protein was further confirmed by 15N-HSQC NMR experiments Structural modifications on the lead compound were guided by the outcomes of mol. modeling studies. Among the 42 compounds obtained, a number of them exhibited much improved binding affinities to Bcl-2 family proteins as compared to the lead compound The most potent compound, BCL-LZH-40 (I), inhibited the binding of BH3 peptides to Bcl-xL, Bcl-2, and Mcl-1 with inhibition constants (Ki) of 17, 534, and 200 nM, resp.

There is still a lot of research devoted to this compound(SMILES：CCC1=CC=C(CBr)C=C1)Recommanded Product: 1-(Bromomethyl)-4-ethylbenzene, and with the development of science, more effects of this compound(57825-30-6) can be discovered.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Computed Properties of C9H11Br. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: 1-(Bromomethyl)-4-ethylbenzene, is researched, Molecular C9H11Br, CAS is 57825-30-6, about Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors. Author is Guo, Jianpeng; Yu, Wenying; Cai, Guiping; Zhang, Wenda; Li, Shanshan; Zhu, Jiawen; Song, Dongmei; Kong, Lingyi.

Persistent activated STAT3 has a striking correlation with cancer development and inhibition of STAT3 signaling pathway is a novel therapeutic way for human cancers. Among STAT family, STAT1 and STAT3 play opposite roles in tumorigenesis. However, the discovery of selective STAT3 inhibitors is still challenging to date. In this study, a series of small-mol. (MW<500) benzensulfanilamide derivatives were designed to selectively suppress STAT3 activation for anti-cancer treatment. The most potent compound 11 inhibited both overexpressed and IL-6 induced STAT3 phosphorylation, whereas 11 displayed little effect on the phosphorylation of other STAT isoforms STAT1, STAT5, demonstrating 11 was a selective STAT3 inhibitor. Meanwhile, 11 dismissed STAT3 DNA binding activity and colony formation. In addition, 11 elevated the ROS level and induced apoptosis of cancer cells. Furthermore, 11 effectively suppressed tumor growth in an in vivo mouse-xenograft model. There is still a lot of research devoted to this compound(SMILES：CCC1=CC=C(CBr)C=C1)Computed Properties of C9H11Br, and with the development of science, more effects of this compound(57825-30-6) can be discovered.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Recommanded Product: 57825-30-6. So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic. Compound: 1-(Bromomethyl)-4-ethylbenzene, is researched, Molecular C9H11Br, CAS is 57825-30-6, about Reactions in microemulsion media. Nucleophilic substitution reactions of benzyl and p-alkylbenzyl chlorides.

The nucleophilic substitution rates of Br- with p-RC6H4CH2Cl (R = H, Et, n-dodecyl) decreased differentially with increasing hexane content in microemulsions formed from ternary hexane systems at constant ratios of the binary mixtures of 1.23:1 (weight/weight) CTAB-1-butanol and 1:5 (weight/weight) KBr-H2O. The kinetics show that the interphase was the microemulsion reactive site. For microemulsions with respect to aqueous micellar and aqueous EtOH reaction mediums, substrate solubilization was higher, initial reaction rates were comparable or a little less, and overall conversions were greater.

If you want to learn more about this compound(1-(Bromomethyl)-4-ethylbenzene)Recommanded Product: 57825-30-6, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(57825-30-6).

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

The chemical properties of alicyclic heterocycles are similar to those of the corresponding chain compounds. Compound: 1-(Bromomethyl)-4-ethylbenzene, is researched, Molecular C9H11Br, CAS is 57825-30-6, about Bifunctional N-aminopyridinium reagents enable C-H amination, olefin carboamination cascades, the main research direction is bifunctional aminopyridinium reagent carbon hydrogen amination; tetrahydroisoquinoline preparation olefin carboamination aminopyridinium.Application of 57825-30-6.

C-H amination reactions provide streamlined access to nitrogen-containing small mols. Here, we disclose benzylic C-H amination with N-aminopyridiniums, which are bifunctional reagents that provide avenues for further diversification. Reductive activation of the incipient N-N bonds unveils electrophilic N-centered radicals, which can be engaged by nucleophilic partners such as olefins, silyl enol ethers, and electron-rich eterocycles. We highlight the synthetic potential of these sequences in the synthesis of tetrahydroisoquinolines, which are important heterocycles in mol. therapeutics, via anti-Markovnikov olefin carboamination. Unlike many C-H amination reactions that provide access to protected amines, the current method installs an easily diversifiable synthetic handle that serves as a lynchpin for C-H amination, deaminative N-N functionalization sequences.

If you want to learn more about this compound(1-(Bromomethyl)-4-ethylbenzene)Application of 57825-30-6, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(57825-30-6).

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Recommanded Product: 1-(Bromomethyl)-4-ethylbenzene. The reaction of aromatic heterocyclic molecules with protons is called protonation. Aromatic heterocycles are more basic than benzene due to the participation of heteroatoms. Compound: 1-(Bromomethyl)-4-ethylbenzene, is researched, Molecular C9H11Br, CAS is 57825-30-6, about Discovery and Development of Thiazolo[3,2-a]pyrimidinone Derivatives as General Inhibitors of Bcl-2 Family Proteins. Author is Zhou, Bingcheng; Li, Xun; Li, Yan; Xu, Yaochun; Zhang, Zhengxi; Zhou, Mi; Zhang, Xinglong; Liu, Zhen; Zhou, Jiahai; Cao, Chunyang; Yu, Biao; Wang, Renxiao.

A class of compounds with a common thiazolo[3,2-a]pyrimidinone motif has been developed as general inhibitors of Bcl-2 family proteins. The lead compound was originally identified in a random screening of a small compound library using a fluorescence polarization-based competitive binding assay. Its binding to the Bcl-xL protein was further confirmed by 15N-HSQC NMR experiments Structural modifications on the lead compound were guided by the outcomes of mol. modeling studies. Among the 42 compounds obtained, a number of them exhibited much improved binding affinities to Bcl-2 family proteins as compared to the lead compound The most potent compound, BCL-LZH-40 (I), inhibited the binding of BH3 peptides to Bcl-xL, Bcl-2, and Mcl-1 with inhibition constants (Ki) of 17, 534, and 200 nM, resp.

If you want to learn more about this compound(1-(Bromomethyl)-4-ethylbenzene)Recommanded Product: 1-(Bromomethyl)-4-ethylbenzene, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(57825-30-6).

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Heterocyclic compounds can be divided into two categories: alicyclic heterocycles and aromatic heterocycles. Compounds whose heterocycles in the molecular skeleton cannot reflect aromaticity are called alicyclic heterocyclic compounds. Compound: 57825-30-6, is researched, Molecular C9H11Br, about Synthesis and antifungal activity of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-(N-butyl-N-substituted benzylamino)-2-propanol, the main research direction is triazole difluorophenyl butylbenzylamino propanol preparation antifungal agent.Recommanded Product: 57825-30-6.

To study the antifungal activity of triazole alcs. by introducing N-Bu and substituted benzyl as side chain, fourteen title compounds were synthesized and characterized by 1H NMR, IR, and LC-MS. The MICs of the compounds were determined by in vitro test using 8 clin. pathogenic fungi. The title compounds exhibited potent antifungal activities against nearly all fungi tested (except for Aspergillus fumigatus), especially for the deep infection ones. Three compounds showed a 16-fold activity (with a MIC80 value of 0.015 6 μg/mL) as that of fluconazole against Microsporum gypseum. Two compounds showed a 128-fold activity (with a MIC80 value of 0.003 9 μg/mL) as that of fluconazole against Candida albicans, and their activities were higher than those of other pos. controls.

If you want to learn more about this compound(1-(Bromomethyl)-4-ethylbenzene)Recommanded Product: 57825-30-6, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(57825-30-6).

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider